BTSMX vs. KMVAX

Last updated Jun 5, 2026

BTSMX (Boston Trust SMID Cap Fund) and KMVAX (Kirr Marbach Partners Value Fund) are both Mid Cap Blend Equities funds. Over the past 10 years, BTSMX returned 10.44%/yr vs 11.38%/yr for KMVAX. Their correlation of 0.89 suggests significant overlap in exposure. BTSMX charges 0.75%/yr vs 1.45%/yr for KMVAX.

Performance

BTSMX vs. KMVAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Trust SMID Cap Fund (BTSMX) and Kirr Marbach Partners Value Fund (KMVAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BTSMX achieves a 2.69% return, which is significantly lower than KMVAX's 13.83% return. Over the past 10 years, BTSMX has underperformed KMVAX with an annualized return of 10.44%, while KMVAX has yielded a comparatively higher 11.38% annualized return.

BTSMX

• 1D: 0.16%
• 1M: 1.28%
• YTD: 2.69%
• 6M: 2.43%
• 1Y: 5.89%
• 3Y*: 8.76%
• 5Y*: 5.54%
• 10Y*: 10.44%

KMVAX

• 1D: -0.18%
• 1M: -0.55%
• YTD: 13.83%
• 6M: 10.57%
• 1Y: 22.09%
• 3Y*: 22.31%
• 5Y*: 13.11%
• 10Y*: 11.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BTSMX vs. KMVAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BTSMX Boston Trust SMID Cap Fund	2.69%	0.72%	10.16%	13.14%	-12.02%	35.06%	8.27%	30.51%	-5.63%	17.69%
KMVAX Kirr Marbach Partners Value Fund	13.83%	14.44%	27.82%	20.42%	-16.01%	28.83%	2.96%	27.03%	-19.72%	16.12%

Correlation

The correlation between BTSMX and KMVAX is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.66
Correlation (3Y) Calculated over the trailing 3-year period	0.76
Correlation (5Y) Calculated over the trailing 5-year period	0.84
Correlation (10Y) Calculated over the trailing 10-year period	0.88
Correlation (All Time) Calculated using the full available price history since Dec 2, 2011	0.89

Over the past year, the correlation between BTSMX and KMVAX has dropped to 0.66 - well below their long-term average of 0.89, suggesting their price drivers have been diverging.

Return for Risk

BTSMX vs. KMVAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTSMX

BTSMX Risk / Return Rank: 6
BTSMX Sharpe Ratio Rank: 6
BTSMX Sortino Ratio Rank: 6
BTSMX Omega Ratio Rank: 6
BTSMX Calmar Ratio Rank: 7
BTSMX Martin Ratio Rank: 7

KMVAX

KMVAX Risk / Return Rank: 26
KMVAX Sharpe Ratio Rank: 25
KMVAX Sortino Ratio Rank: 25
KMVAX Omega Ratio Rank: 24
KMVAX Calmar Ratio Rank: 34
KMVAX Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BTSMX vs. KMVAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Trust SMID Cap Fund (BTSMX) and Kirr Marbach Partners Value Fund (KMVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BTSMX	KMVAX	Difference
Sharpe ratio: Return per unit of total volatility	0.44	1.42	-0.98
Sortino ratio: Return per unit of downside risk	0.75	2.06	-1.31
Omega ratio: Gain probability vs. loss probability	1.08	1.25	-0.17
Calmar ratio: Return relative to maximum drawdown	0.63	2.15	-1.52
Martin ratio: Return relative to average drawdown	1.76	5.88	-4.12
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BTSMX vs. KMVAX - Sharpe Ratio Comparison

The current BTSMX Sharpe Ratio is 0.44, which is lower than the KMVAX Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of BTSMX and KMVAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BTSMX	KMVAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.44	1.42	-0.98
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.33	0.72	-0.38
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.57	0.57	0.00
Sharpe Ratio (All Time) Calculated using the full available price history	0.61	0.42	+0.19

Drawdowns

BTSMX vs. KMVAX - Drawdown Comparison

The maximum BTSMX drawdown since its inception was -38.04%, smaller than the maximum KMVAX drawdown of -65.81%. Use the drawdown chart below to compare losses from any high point for BTSMX and KMVAX.

Drawdown Indicators

	BTSMX	KMVAX	Difference
Max Drawdown Largest peak-to-trough decline	-38.04%	-65.81%	+27.77%
Max Drawdown (1Y) Largest decline over 1 year	-8.74%	-10.22%	+1.48%
Max Drawdown (3Y) Largest decline over 3 years	-20.28%	-21.26%	+0.98%
Max Drawdown (5Y) Largest decline over 5 years	-21.46%	-24.84%	+3.38%
Max Drawdown (10Y) Largest decline over 10 years	-38.04%	-45.41%	+7.37%
Current Drawdown Current decline from peak	-4.70%	-1.21%	-3.49%
Average Drawdown Average peak-to-trough decline	-4.99%	-9.98%	+4.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.12%	3.74%	-0.62%

Volatility

BTSMX vs. KMVAX - Volatility Comparison

The current volatility for Boston Trust SMID Cap Fund (BTSMX) is 2.57%, while Kirr Marbach Partners Value Fund (KMVAX) has a volatility of 4.10%. This indicates that BTSMX experiences smaller price fluctuations and is considered to be less risky than KMVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BTSMX	KMVAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.57%	4.10%	-1.53%
Volatility (6M) Calculated over the trailing 6-month period	8.32%	11.76%	-3.44%
Volatility (1Y) Calculated over the trailing 1-year period	12.61%	15.56%	-2.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.76%	18.39%	-1.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.38%	20.14%	-1.76%

BTSMX vs. KMVAX - Expense Ratio Comparison

BTSMX has a 0.75% expense ratio, which is lower than KMVAX's 1.45% expense ratio.

Dividends

BTSMX vs. KMVAX - Dividend Comparison

BTSMX's dividend yield for the trailing twelve months is around 2.00%, less than KMVAX's 4.65% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BTSMX Boston Trust SMID Cap Fund	2.00%	2.05%	2.20%	0.79%	4.15%	6.35%	0.77%	6.33%	1.95%	0.47%	6.36%	7.34%
KMVAX Kirr Marbach Partners Value Fund	4.65%	5.30%	7.58%	3.35%	3.57%	3.72%	1.35%	2.11%	9.38%	6.87%	5.64%	0.34%

Frequently Asked Questions

Can I hold both BTSMX and KMVAX in my portfolio?

BTSMX and KMVAX have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BTSMX or KMVAX?

KMVAX has higher volatility (4.10%) compared to BTSMX (2.57%). In terms of maximum drawdown, BTSMX dropped -38.04% vs KMVAX's -65.81%.

Which has better risk-adjusted returns?

KMVAX currently has the higher Sharpe Ratio (1.42 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.